IV antihypertensives in hypertensive emergency: controlled lowering and drug cues

Controlled lowering matters more than reaching normal fast

Organs in long-standing hypertension adapt their blood-flow autoregulation to high pressures. A rapid drop can therefore cause cerebral, coronary or renal ischaemia. General guidance lowers blood pressure by no more than 25% in the first hour, then towards a moderate target over the following hours, with further lowering over a day or two.

Exceptions follow the underlying problem. Aortic dissection calls for rapid lowering of pressure and heart rate, while acute ischaemic stroke usually involves more cautious targets. In exam questions, read the diagnosis before judging whether a falling reading is desirable or dangerous. Continuous monitoring, often with an arterial line, supports accurate titration.

Calcium channel blockers: nicardipine and clevidipine

Nicardipine and clevidipine are dihydropyridine calcium channel blockers that dilate arterioles and can be titrated in small steps. Clevidipine acts and wears off within minutes, so an interrupted infusion can let pressure rebound quickly. Watch for reflex tachycardia, headache, flushing and hypotension, and check the infusion site for phlebitis.

Clevidipine is a lipid emulsion. That makes egg or soy allergy and disorders of lipid metabolism relevant, and the emulsion needs strict aseptic handling. A nurse who recognises the milky appearance should not confuse it with propofol, and should check the allergy list before hanging the bag.

Labetalol and nitroprusside, including cyanide cues

Labetalol blocks alpha and beta receptors, lowering pressure without reflex tachycardia. Its beta blockade makes asthma, decompensated heart failure, bradycardia and heart block important cautions. Check heart rate and listen for wheeze before and after doses, and position the patient supine because postural hypotension can occur.

Nitroprusside is a powerful arterial and venous dilator with very rapid onset that can drop pressure precipitously, and it is metabolised to cyanide. Cyanide risk rises with higher infusion rates and prolonged use, while its metabolite thiocyanate accumulates in renal impairment. Unexplained metabolic acidosis, rising lactate, air hunger, confusion or a falling response to the drug are cues to report. The solution is diluted before use and protected from light.

Hold, report and handover points for vasoactive infusions

Clarify the order before starting if it lacks a target range, maximum rate or titration interval. Pause or reduce the infusion and notify the prescriber for blood pressure below the target, new neurological deficit, chest pain, symptomatic bradycardia on labetalol, or wheeze in a patient with reactive airways. Keep emergency equipment and the protocol at hand.

For nitroprusside, report the infusion duration, any rising lactate or acid-base change and kidney results at each handover, because cyanide and thiocyanate risk accumulate over time. When the patient begins oral antihypertensives, expect a planned weaning of the infusion rather than abrupt stopping, and monitor for rebound hypertension as short-acting drugs wear off.

Nursing actions and an original scenario

Use a dedicated line and an infusion pump, label clearly, and confirm the order's target range and titration limits. Reassess neurological status, chest pain, urine output and vision as the pressure falls, because new symptoms may signal hypoperfusion. Hand over the current rate, the latest trend and the next planned review.

In a hypothetical case, a patient with hypertensive encephalopathy on nicardipine drops from a very high reading to a near-normal one within forty minutes and becomes drowsier. Choices are to continue because the number looks good, increase the rate to finish the job, or reduce the infusion per protocol and notify the prescriber. Reducing and notifying is correct, because overly rapid lowering risks cerebral hypoperfusion. Continuing because the reading looks normal confuses a number with a goal, and increasing the rate compounds the harm. The drowsiness is the clinical cue that changes the priority from lowering pressure to protecting perfusion.

Sources and further reading

StatPearls: Hypertensive Crisis. First-hour lowering limit, exceptions, first-line IV agents, clevidipine allergy, labetalol cautions and arterial line monitoring.

StatPearls: Vasodilators. Nitroprusside metabolism to cyanide, risk factors, timing of toxicity and sodium thiosulfate treatment.

DailyMed: Sodium nitroprusside injection prescribing information. Boxed warnings on precipitous hypotension, required dilution and cyanide toxicity; signs including metabolic acidosis and confusion; thiocyanate limits in renal impairment; caution in hepatic insufficiency; light protection.